Company / SG&A Expense
PROTHENA CORP PUBLIC LTD CO SG&A Expense History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$61.8M
FY2025
5-year range
$35.7M / $61.8M
FY2021-FY2025
Trend
+23.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
SG&A Expense has increased for 4 consecutive years, from $36M in FY2021 to $62M in FY2025.
Based on SEC 10-K filings.
$62M in FY2025 with a 5-year CAGR of +7.8%.
Increased from $46M to $62M over the past 2 years.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- +16.9%
- 5-Year CAGR
- +7.8%
- 10-Year CAGR
- -
Key checks
Key Insights
- PROTHENA CORP PUBLIC LTD CO's sg&a expense has grown for 4 consecutive years.
- 5-year CAGR of +7.8%, indicating consistent growth.
- In FY2025, sg&a expense increased 23.9% year-over-year.
- Lowest sg&a expense in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $61.8M | +23.9% |
| FY2024 | $49.9M | +7.7% |
| FY2023 | $46.3M | +19.7% |
| FY2022 | $38.7M | +8.3% |
| FY2021 | $35.7M | -15.9% |
| FY2020 | $42.5M | -11.9% |
| FY2019 | $48.2M | +17.5% |
| FY2018 | $41.1M | +77.7% |
| FY2017 | $23.1M | +21.3% |
| FY2016 | $19.1M | +26.6% |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 28, 2026